Human CHD5 adenoviral particles

The CHD5 (chromodomain helicase DNA-binding protein 5) gene is a key member of the CHD family of chromatin remodeling proteins, which play a key role in regulating gene expression by modifying chromatin structure. CHD5 is located in the p36 region of chromosome 1, which is frequently deleted in human cancers. CHD5 functions as a tumor suppressor by affecting processes such as cell proliferation, differentiation, and apoptosis. It is highly expressed in neural tissues and has been implicated in neural development and maintaining genomic stability. CHD5 is able to remodel nucleosomes and recruit other epigenetic modifiers. Mutations or loss of CHD5 expression are associated with a variety of malignancies, including neuroblastoma, glioblastoma, and breast cancer, making it a promising target for therapeutic intervention.

Human CHD5 Adenoviral Particles are genetically engineered viral vectors designed to deliver the CHD5 gene to target cells for research or potential therapeutic purposes. These particles are based on adenovirus, a non-enveloped DNA virus optimized for high transduction efficiency in both dividing and non-dividing cells. Adenoviral CHD5 particles are valuable tools for studying the tumor suppressor functions of CHD5, such as its role in cell cycle arrest, senescence induction, and epigenetic reprogramming. Researchers use these vectors to overexpress CHD5 in cancer cell lines or animal models to study its mechanistic role and therapeutic potential.